Physician profile
Anthony Oddo
NPI 1538375720
$709.15
in general payments reported to CMS, 2019-2025
11 companies · $143 in 2025
The $143 reported for 2025 was more than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $125 · 2020: $49.40 · 2021: $166 · 2022: $51.78 · 2023: $38.72 · 2024: $134 · 2025: $143.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $316.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $316.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $150.86 | 2019-2025 | |
| Bioness INC | $137.46 | 2021 | |
| Abbvie INC. | $94.38 | 2022-2024 | |
| Medtronic, INC. | $82.56 | 2021-2025 | Synchromedii |
| Curonix LLC | $72.49 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Vertex Pharmaceuticals Incorporated | $41.64 | 2024-2025 | |
| Allergan, INC. | $37.49 | 2020-2021 | |
| Pacira Therapeutics, INC. | $24.27 | 2020 | |
| Baxter Healthcare | $22.97 | 2025 | Floseal |
| Stryker Corporation | $22.64 | 2024 | Gamma, T2 Alpha |
| Pinnacle, INC | $22.39 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Oddo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.